Regeneron Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2008 | -18.8% | -18.8% | — |
| FY2009 | -17.1% | -17.1% | -9.2% |
| FY2010 | -19.8% | -19.8% | -9.6% |
| FY2011 | -45.7% | -45.7% | -16.8% |
| FY2012 | 59.7% | 59.7% | 36.1% |
| FY2013 | 21.1% | 21.1% | 14.0% |
| FY2014 | 13.3% | 13.3% | 8.8% |
| FY2015 | 17.4% | 17.4% | 11.3% |
| FY2016 | 20.1% | 20.1% | 12.8% |
| FY2017 | 19.5% | 19.5% | 13.7% |
| FY2018 | 27.9% | 27.9% | 20.8% |
| FY2019 | 19.1% | 19.1% | 14.3% |
| FY2020 | 31.9% | 27.0% | 20.5% |
| FY2021 | 43.0% | 38.9% | 31.7% |
| FY2022 | 19.1% | 17.6% | 14.9% |
| FY2023 | 15.2% | 14.1% | 12.0% |
| FY2024 | 15.0% | 14.1% | 11.7% |
| FY2025 | 14.4% | 13.6% | 11.1% |